Rapid and high-throughput detection of biomarkers plays an important role in disease diagnosis, prognosis, and monitoring treatment. Existing diagnostic tools that rely on genetic testing and antibody recognition can provide the required sensitivity and specificity. However, these methods need multiple labeling steps for the signal amplification, which are tedious and time-consuming. To address these issues, self-assembled colloidal superstructures, especially for the nanophotonic structures, exhibit many optical sensing properties in response to external stimuli, which lays the foundation for developing the next-generation biosensors. Herein, we discuss the potential of self-assembled nanophotonic-based biosensors for achieving low-cost, high-sensitive, multiplexed detection of various biomarkers, including nucleic acids, proteins, and exosomes. We conclude the current challenges in optical colloidal biosensors and offer insights into their further advances towards the smart healthcare.
Gyms are indoor environments in which many people perform physical exercise and could potentially increase the risks of bacterial contamination and dissemination. Staphylococcus aureus (S. aureus) is one of the most prevalent bacteria in community-acquired infections; thus, the rapid detection and continuous monitoring of S. aureus are crucial for evaluating the hygienic status of gym environments. This work describes the fabrication of a nanochain-based biosensor for S. aureus detection using carboxyl-modified polystyrene (PS) nanoparticles functionalized with a specific antibody. When target bacteria bind to the nanochains, they yield distinct color changes which support the directly visualizable analysis of optical images, recorded using optical microscopy or even a smart mobile phone. In addition to high portability, this biosensor is also capable of the quantification and continuous monitoring of the bacterial load in a gym environment over a broad linear range (100 CFU/mL~105 CFU/mL), with a detection limit of 1 CFU/mL. In summary, this study validated the applicability of the biosensors for the rapid detection and real-time monitoring of gym environmental pathogens.
Traumatic brain injury (TBI) triage and monitoring demand rapid, sensitive, and deployable biomarker assays. We present an AI-integrated nanophotonic biosensor enabling ultrasensitive multiplexed quantification of S100B, GFAP, and UCH-L1 across diverse human biofluids. The sensing substrate consists of polystyrene single chains formed via liquid-confinement self-assembly and functionalized with antibodies. Selenium nanoparticles are pre-incubated with specimens to form SeNP–antigen complexes that co-localize on the chains, generating high-contrast elastic scattering. A standardized four-zone layout employs hydrophilic/hydrophobic patterning to passively isolate reaction domains without physical barriers. A deep learning pipeline facilitates device-agnostic quantification from images captured using various microscopy systems, including professional setups and smartphone-based adaptations. Validation with 195 clinical specimens from 75 individuals (TBI patients and controls) spanning serum, urine, saliva, and cerebrospinal fluid demonstrated a detection limit of 1 pg mL−1 and strong agreement with ELISA (R2 > 0.93) for all biomarkers, with consistent performance across imaging modalities. The workflow is completed in ∼30 min and requires only a smartphone in portable modes, demonstrating a proof-of-concept for point-of-care neurotrauma diagnostics and highlighting a potential pathway toward AI-assisted decentralized TBI management.